Respiratory Physiology Education Day - July 2017

Photo by Tom Psomotragos

Photo by Tom Psomotragos

Covering the intermediate to advanced aspects of pulmonary physiology with a focus on airways disease, this education day will provide a basis by which attendees can further learn about complex physiology, in relation to airways disease. 

This comprehensive education day is primarily aimed at respiratory medicine trainees, physicians and respiratory scientists. However, the content may be of interest to all respiratory healthcare professionals.

Click here to view the program.

When: Saturday, 29 July 2017. 9am - 5pm

Location: Level 5, Woolcock Institute, 431 Glebe Point Road, Glebe NSW 2037

Cost: $20 Catering provided. Places limited.

This educational activity is supported by an independent educational grant from GlaxoSmithKline Australia. 

GP Seminar

SLEEP, MOOD AND NEURODEGENERATIVE DISORDERS: IDENTIFICATION AND MANAGEMENT IN GERIATRIC PATIENTS

The Woolcock NeuroSleep Clinic, invites you to a special free GP Seminar on 21 June 2017 at the Brain and Mind Centre.

Join us as we consider and discuss issues commonly faced by GPs when treating older adults including the assessment, treatment and management of common sleep, psychiatric, neurological and neurodegenerative disorders. We will also introduce you to our specialised research clinics, which offer free assessments and interventions to eligible participants. Come along to hear the latest research, discuss relevant case studies and identify alternative assessments and treatments that may assist your practice.

Click here to view the program. 

About this course: This Category 2 activity has been approved by the RACGP QI&CPD Program. Total Points: 4 CPD points. Activity Number: 102425.

When: Wednesday, 21 June 2017. 5.45pm - 8.30pm

Location: Brain and Mind Centre, Lecture Theatre, Level 5, 94 Mallett Street, Camperdown NSW 2050

Cost: Free. Light refreshments provided.

Institute Celebrates Trailblazing Women Scientists

Australia’s top respiratory health institute will mark International Women’s Day with a lecture from one of the world’s most esteemed women scientists in honour of its own celebrated female founder.

The Woolcock Institute of Medical Research in Sydney has invited world-leading respiratory physician Dirkje Postma, Professor of Pathophysiology at the University of Groningen in the Netherlands, to speak on March 8.

The Ann Woolcock Lecture commemorates the institute’s own trailblazing female founder, whose work revolutionised asthma treatment worldwide. With four women on its board and a female director at its helm, the Woolcock has shown it’s serious about nurturing and promoting women in science.

“We’re excited to be able to host such an eminent female researcher at the Woolcock on such important occasion as International Women’s Day,” Executive Director Professor Carol Armour says.

“Like our own Ann Woolcock, Dirkje Postma enjoys international recognition as a scientist who revolutionised our understanding of respiratory illnesses and how to treat them. Thanks to their work, and the work of a growing number of influential women scientists around the world, we’re closer than ever to beating these diseases.”

Professor Postma will use the lecture to talk about exciting developments in chronic obstructive pulmonary disease or COPD, the generic term for a number of lung diseases, including emphysema and chronic bronchitis that cause coughing, wheezing and shortness of breath.

The disease affects 14 per cent of Australians aged 40 or over, and 29 per cent of those aged 75 or over.[i] There is no cure and while cigarettes are recognised as a key trigger, one in five patients have never smoked.

Professor Postma will detail exciting new developments in the field that are revealing just how complex the condition is. Far from a simple ‘smoker’s disease’, COPD can also be triggered by chemical exposure, premature birth, genetics, ageing, or a combination of these factors. She will explain how this deeper understanding of COPD and its many faces will pave the way to personalised treatment that better suits the individual patient’s disease history.

“To consider a time when patients with COPD will get tailored care specific to their disease is exciting indeed,” Professor Armour. “It heralds the beginning of better, faster, more effective treatment that helps sufferers retain good quality of life for longer.”

The Ann Woolcock Lecture series honours the contribution of Professor Woolcock to the research community. Invited researchers share their ideas with industry, policy makers, fellow academics, doctors, specialists and patients with a view to prompting new collaborations to improve respiratory health.

The lecture, COPD: A Disease With Many Faces, will be held on Wednesday, 8 March at 5.30pm, at the Woolcock Institute of Medical Research headquarters in Glebe, Sydney. RSVP to woolcock.admin@sydney.edu.au or phone 02 9114 0408.

[i] Toelle, B. G., Xuan, W., Bird, T. E., Abramson, M. J., Atkinson, D. N., Burton, D. L., James, A. L., Jenkins, C. R., Johns, D. P., Maguire, G. P., Musk, A. W., Walters, E., Wood-Baker, R., Hunter, M. L., Graham, B. J., Southwell, P. J., Vollmer, W. M., Buist, A., & Marks, G. B. (2013). Respiratory symptoms and illness in older Australians: The Burden of obstructive Lung Disease (BOLD) study. Medical Journal of Australia, 198(3), 144-148.

Mild Asthma Study

Asthma

A NEW INHALER FOR MILD ASTHMA? 

Do you have mild asthma and are using mainly a blue reliever? 

A new inhaler for mild asthma is being tested at the Woolcock Institute. 

  • Free inhalers, lung function tests and assessment of your asthma 
  • You will be reimbursed for study visits 

Do you want to participate in this study?

Click here to register online.

Email: novelstart@woolcock.org.au

For more information about this study click here.